Fortive Corporation (FTV)

FairStock Score: 39/100 — MIXED

Key Financials

Strengths

• Strong free cash flow generation of $856M annually with 2.5% yield providing operational visibility
• Q4 2025 net margin of 16.54% demonstrates operational efficiency and pricing power
• Diversified revenue streams across Industrial IoT and Healthcare segments reducing concentration risk
• Reasonable debt-to-equity ratio of 0.51 indicating conservative capital structure
• Piotroski F-Score of 7/9 suggesting solid underlying business quality and earnings durability

Concerns

• Severely elevated valuation with P/E of 34.73 versus abysmal ROE of 6.4% and ROCE of 3.13%—capital returns far below cost
• EV/EBITDA of 61.39x is indefensible; no moat visible to justify premium technology multiples
• Graham Number of $16.53 versus $56.35 price implies negative margin of safety and significant downside risk
• Absence of revenue and profit growth metrics raises questions about organic growth trajectory and sustainability
• Altman Z-Score of 2.78 suggests moderate financial distress despite positive cash flow

AI Analysis

Looking at Fortive, I find myself deeply uncomfortable with the valuation relative to the business quality on display. Yes, the company generates respectable free cash flow of $856 million annually, and the latest quarter showed a healthy 16.5% net margin. The diversification across Intelligent Operating Solutions and Advanced Healthcare Solutions provides some stability. However, the fundamentals don't justify the price. A P/E of 34.73 when the company's ROE is merely 6.4% and ROCE sits at 3.13% is frankly alarming. These returns are substantially below our cost of capital. The EV/EBITDA multiple of 61.39x is exorbitant—I'd expect to pay that for a compounder, not a business generating single-digit returns on capital. Graham's margin of safety is completely absent here; we're 240% above the Graham Number. The Piotroski F-Score of 7/9 suggests decent operational quality, but the Altman Z-Score of 2.78 indicates moderate financial stress. This is a business trading at premium technology multiples while delivering industrial-grade economics. The 2.5% FCF yield is uncompelling for the risk. I see a company that's decently run but offering no margin of safety, no clear competitive moat, and returns on capital that won't create shareholder wealth. At this price, I'm a seller, not a buyer.

Bull Case

Fortive's portfolio of software and recurring services could drive margin expansion toward 18-20% as the mix shifts, while digital transformation tailwinds in industrial monitoring and healthcare could unlock 5-7% organic growth. Strong cash generation provides a safety net and capital for strategic acquisitions that enhance ROCE.

Bear Case

A recession in industrial end-markets or healthcare spending pullback could compress margins below 14%, while the poor ROCE of 3.13% suggests management capital allocation has been mediocre. At current valuations, even modest growth disappointment could trigger a 25-35% correction.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer